Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is being conducted to compare the safety and effectiveness of the investigational
medication LdT (telbivudine) used in combination with adefovir dipivoxil (a drug currently
approved by the Food and Drug Administration [FDA] for the treatment of hepatitis B virus
[HBV]) versus adefovir dipivoxil used alone. The results for patients taking the combination
therapy will be compared to the results for patients taking adefovir alone.